Importantly, blocking STAT signaling with the small-molecule inhibitor Ganetespib56 suppressed the nonautonomous growth-inducing effect of p53OE and IR on both breast and lung cancer cells (Fig. 4f, g, k, l, and supplementary Fig. 6). This evidence concerns the gene SOAT1 and lung cancer.